Order results by:
| Issue | Title | |
| Vol 13, No 2 (2020) | Improvements to the formation of lists of drugs for medical use: analysis of changes in the Government Decree no. 871 | Abstract similar documents |
| V. V. Omelyanovskiy, E. A. Maksimkina, O. I. Ivakhnenko, M. V. Avxentyeva, M. V. Sura, G. R. Khachatryan | ||
| "... investigation. The changes affecting both the order and the procedure of forming the lists of medical drugs ..." | ||
| Vol 11, No 3 (2018) | The concept of multi-criteria analysis of decision-making in the current system of health technology assessment in Russia | Abstract similar documents |
| V. V. Omelyanovsky, V. K. Fedyaeva, N. Z. Musina | ||
| "... In the article, we analyze the current version of Government Regulation No. 871 where ..." | ||
| Vol 14, No 1 (2021) | Development of a method for the analysis of the lists of medicines and its application for the analysis of the lists of medicines in Russia, England, and Italy | Abstract similar documents |
| V. A. Lemeshko, K. I. Matrenin, V. V. Omelyanovskiy, Yu. V. Vasilyeva, G. R. Khachatryan, L. A. Kolganov | ||
| "... to the formation of the lists of medicines required for medical help in Russia, England, and Italy and reimbursed ..." | ||
| Vol 10, No 1 (2017) | RESTRICTIVE LISTS OF DRUGS: REGULATIONS, FUNCTIONS, SOURCES OF FINANCE, AND GUIDELINES FOR CREATION | Abstract similar documents |
| M. V. Sura | ||
| "... of “7 medical conditions”, the minimum assortment, the lists of regional benefits, the lists ..." | ||
| Vol 16, No 2 (2023) | Methodological approach to the formation of the list of high-tech medical care types | Abstract similar documents |
| I. A. Zheleznyakova, O. A. Volkova, D. V. Fedyaev, A. V. Zuev, O. S. Plakhotnik, G. V. Trifonova, Yu. S. Zueva, I. A. Alexandrov, V. V. Omelyanovskiy | ||
| "... , including the list of medical services approved by the Order of the MH RF of October 13, 2017 No. 804n ..." | ||
| Vol 11, No 3 (2018) | What is the role of antineoplastic drug safety in reimbursement decision making? | Abstract similar documents |
| A. S. Kolbin, A. A. Kurylev | ||
| "... /noninclusion into VeD lists. Results. The mean safety score for all drugs of this group was -4,67 (95% CI from ..." | ||
| Vol 9, No 1 (2016) | MATHEMATICAL MODEL OF REIMBURSEMENT DECISION MAKING IN RUSSIA. RESULTS OF VIM LIST FOR 2016 | Abstract similar documents |
| A. S. Kolbin, A. V. Prasolov, E. A. Maksimkina, Yu. E. Balykina, Z. M. Golant, Yu. S. Polushin, A. A. Kurylev, I. A. Vilyum | ||
| "... inclusion and exclusion into the reimbursement lists in Russian Federation. The liner mathematical model ..." | ||
| Vol 11, No 4 (2018) | Patient registers and account registries of compulsory medical insurance: integration and replaceability | Abstract similar documents |
| I. A. Zheleznyakova, G. I. Pirova, E. A. Proxorovich | ||
| "... and the effectiveness of medical care provided to patients. The registers also represent a source of information ..." | ||
| Vol 9, No 3 (2016) | DRUGS PROVIDED TO BREAST CANCER PATIENTS WITHIN THE STATE PROGRAMS OF DRUG SUPPLY | Abstract similar documents |
| M. V. Avxentyeva, V. I. Bogin, E. V. Derkach, V. V. Omelyanovskiy, M. B. Stenina, A. V. Tarakanov, M. Yu. Frolov | ||
| "... препаратов, включенных и не включенных в стандарты медицинской помощи, перечни лекарственных препаратов ..." | ||
| Vol 8, No 2 (2015) | PRINCIPLES OF IMPORT SUBSTITUTION REGARDING DRUGS | Abstract similar documents |
| Alana Viktorovna Dzaneva, Vitalii Vladimirovich Omel'yanovskii, Saniyat Aleksandrovna Kagermazova | ||
| "... the scope of restriction lists at various levels of the health care system. The article reviews ..." | ||
| Vol 7, No 4 (2014) | ROAD MAP FOR DEVELOPMENT OF PRICE REGULATION SYSTEM AND SYSTEM OF DRUG SUPPLY AT THE EXPENSE OF RUSSIAN FEDERATION HEALTHCARE SYSTEM FUNDS | Abstract similar documents |
| M. V. Sura, K. V. Gerasimova, V. V. Omelyanovskiy, M. V. Avksentieva | ||
| "... for 25 drugs for treatment of malignant neoplasms and cardiovascular diseases, included in the list ..." | ||
| Vol 12, No 4 (2019) | The health technology assessment system in Australia | Abstract similar documents |
| V. V. Omelyanovskiy, E. S. Saybel, T. P. Bezdenezhnykh, G. R. Khachatryan | ||
| "... . The government agencies determine the list of reimbursable pharmaceuticals and medical services and also define ..." | ||
| Vol 18, No 2 (2025) | Data analysis of medicines aimed at health technology assessment within the activities of the “Circle of Kindness” Foundation from 2021 to 2024 | Abstract similar documents |
| V. V. Omelyanovskiy, A. A. Kingshott, T. S. Teptsova, P. A. Mukhortova, A. G. Kharitonova, S. I. Zinadinov, L. O. Krekhtunova, N. A. Aldushchenko, A. А. Kozak, V. A. Ryagina | ||
| "... support for decision-making regarding the inclusion of diseases in the list of diseases and medicines ..." | ||
| Vol 7, No 3 (2014) | ASSESSMENT OF NECESSARY FINANCIAL EXPENSES ON THE DRUG SUPPLY OF THE PATIENTS WITH ORPHAN DISEASES IN THE RUSSIAN FEDERATION | Abstract similar documents |
| M. V. Sura, K. V. Gerasimova, V. V. Omelyanovskiy, M. V. Avksentyeva | ||
| "... with orphan diseases, included in the list of orphan diseases (24 diseases) by the RF Government Regulation ..." | ||
| Vol 14, No 2 (2021) | Organizational and economic aspects of triplet therapy of relapsed/refractory multiple myeloma in the Russian healthcare setting | Abstract similar documents |
| E. A. Pyadushkina, E. V. Derkach, V. I. Ignatyeva, E. E. Yagnenkova, T. Yu. Klitochenko, T. V. Shelekhova, A. N. Levanov | ||
| "... , tariffs under the compulsory medical insurance system were calculated and their sufficiency in covering ..." | ||
| Vol 12, No 3 (2019) | Diagnosis-related groups and payments for the treatment of malignant neoplasms in the model of 2019 | Abstract similar documents |
| D. V. Fedyaev , V. V. Omelyanovskiy , M. L. Lazareva , Yu. V. Seryapina, Yu. A. Ledovskikh | ||
| "... tariffs in the compulsory medical insurance. Especially emphasized are changes made in the DRG model ..." | ||
| Vol 17, No 1 (2024) | Clinical and economic implications of using daratumubab with lenalidomide in the 1st and 2nd lines of therapy for multiple myeloma patients | Abstract similar documents |
| О. I. Ivakhnenko, V. V. Ryazhenov, N. A. Falaleeva | ||
| "... Цель: оценка клинико-экономических последствий добавления лекарственного препарата (ЛП ..." | ||
| Vol 15, No 1 (2022) | Pharmacoepidemiological analysis of medication consumption in a multidepartmental hospital as an element of medical care quality management and the basis for assessing import substitution | Abstract similar documents |
| O. V. Zhukova, O. V. Ruina, M. V. Khazov, T. M. Konyshkina, E. A. Rodin, D. K. Lipatov | ||
| "... and 15.6% in 2018. The analysis of the medication list used in a medical organization, regarding ..." | ||
| Vol 14, No 3 (2021) | Health economic evaluation of risdiplam in patients with spinal muscular atrophy | Abstract similar documents |
| А. S. Kolbin, А. А. Kurylev, Yu. Е. Balykina, М. А. Proskurin, S. А. Mishinova | ||
| "... and nusinersen are both authorized in Russia for pathogenic SMA treatment and included in the list of vital ..." | ||
| Vol 10, No 1 (2017) | PHARMACOECONOMIC ANALYSIS OF BRENTUXIMAB VEDOTIN THERAPY IN RELAPSED OR REFRACTORY CD30+ SYSTEMIC ANAPLASTIC LARGE CELL LYMPHOMA IN PATIENTS OVER 18 YEARS OF AGE: HEALTH BUDGET IMPACT ANALYSIS | Abstract similar documents |
| A. S. Kolbin, I. A. Vilum, М. A. Proskurin, Yu. E. Balykina | ||
| "... that the introduction of brentuximab vetodin in the List of vital and essential drugs and the Program of state ..." | ||
| Vol 10, No 4 (2017) | THE INTERNATIONAL PRACTICE OF DRUG SUPPLY IN THE OUTPATIENT SEGMENT | Abstract similar documents |
| D. V. Lukyantseva, L. S. Mel’nikova, A. P. Tatarinov | ||
| "... В статье рассматривается международный опыт лекарственного обращения и те риски, с которыми ..." | ||
| Vol 16, No 2 (2023) | Development of methodological approaches to the formation of a risk-based model to minimize the prevalence of adverse reactions in drug application in medical organizations of Moscow | Abstract similar documents |
| E. V. Kuznetsova, M. V. Zhuravleva, I. A. Mikhailov, T. I. Kurnosova | ||
| "... a database containing 1,450 drug-related ARs reports from January through December 2021. A list ..." | ||
| Vol 17, No 3 (2024) | Economic analysis of implementing Systemic Coronary Risk Estimation (SCORE2) scale and long-term consequences | Abstract similar documents |
| E. O. Kurilovich, A. V. Nikitina, I. V. Sorokovikov | ||
| "... ) events identified during prophylactic medical examination of the adult population according to the SCORE2 ..." | ||
| Vol 13, No 2 (2020) | Review of calculation methods, procedures for registration and re-registration of producer prices of medicines in the countries of the Eurasian Economic Union | Abstract similar documents |
| A. A. Leshkevich, D. S. Yurochkin, Z. M. Golant, I. A. Narkevich | ||
| "... of Kazakhstan, Republic of Moldova, Republic of Armenia, and the Kyrgyz Republic, the comparison of the list ..." | ||
| Vol 9, No 3 (2016) | EARLY HEALTH TECHNOLOGIES ASSESSMENT — NEW APPROACH TO IMPROVING THE EFFICIENCY OF THE MEDICAL TECHNOLOGY DEVELOPMENT PROCESS | Abstract similar documents |
| N. Z. Musina, V. V. Omelyanovskiy, A. V. Krasheninnikova | ||
| "... of the life cycle of medical technology. This method allows us to optimize the design of clinical trials ..." | ||
| Vol 15, No 2 (2022) | The current state of the veterinary drugs market in the Tyumen Region | Abstract similar documents |
| V. V. Byshenko, О. I. Knysh, L. N. Zadirachenko, А. О. Egorova, Yu. S. Rodina | ||
| "... Objective: to assess the current state of the veterinary medical product market in the Tyumen ..." | ||
| Vol 16, No 2 (2023) | Improving the model of payment for medical care for chronic viral hepatitis C in the framework of the implementation of the Program of State Guarantees of Free Provision of Medical Care to Citizens for 2023 and for the planned period of 2024–2025 | Abstract similar documents |
| V. V. Omelyanovskiy, I. A. Zheleznyakova, A. V. Zuev, O. S. Plakhotnik, O. A. Volkova, L. M. Davydova, G. V. Trifonova, E. V. Semakova, E. A. Prokhorovich, A. S. Volkova | ||
| "... in effect until now, has lost its relevance and cannot be used to pay for cases of medical care for chronic ..." | ||
| Vol 12, No 2 (2019) | Health technology assessment and reimbursement of pharmaceuticals in Italy | Abstract similar documents |
| F. V. Gorkavenko, V. V. Omelyanovskiy, T. P. Bezdenezhnykh, G. R. Khachatryan | ||
| "... by low inter-regional coherence and insufficient coordination. As a result, the access to medical ..." | ||
| Vol 15, No 1 (2022) | The real practice of clinical and economic research of drugs included in the Federal Program of High-Cost Nosologies | Abstract similar documents |
| A. S. Kolbin, Yu. M. Gomon, A. R. Kasimova, A. A. Kurylev, A. E. Bem | ||
| "... databases, a search was made for clinical and economic studies of medicines included in the HCN list ..." | ||
| Vol 11, No 4 (2018) | Treatment of patients with malignant lymphoproliferative diseases in the Russian Federation: analysis of the data from 75 regions | Abstract similar documents |
| G. R. Hachatryan, T. S. Teptsova, V. A. Lemeshko, N. Z. Musina | ||
| "... The aim is to analyze the medical records of patients with malignant lymphoproliferative diseases ..." | ||
| Vol 5, No 2 (2012) | MEDICO-ECONOMIC SUBSTANTIATION OF NORMATIVE STANDARD OF SUPPLYING STUDENTS OF MILITARY SCHOOLS WITH MEDICATIONS | Abstract similar documents |
| Yu. V. Miroshnichenko, V. S. Gaynov | ||
| "... of efficiency of medical supply of students and improving their health state. ..." | ||
| Vol 11, No 3 (2018) | Use of medications in children hospitalized with community-acquired pneumonia | Abstract similar documents |
| D. D. Siukaeva, I. A. Narkevich, V. N. Timchenko, O. D. Nemyatyh, N. A. Maslova | ||
| "... pneumonia. Materials and methods. Medical records of 547 children treated for community-acquired pneumonia ..." | ||
| Vol 5, No 1 (2012) | DYNAMICS OF PREFERENTIAL MAINTENANCE OF CITIZENS WITH ANTIHYPERTENSIVE DRUGS AT THE EXPENSE OF THE REGIONAL BUDGET | Abstract similar documents |
| I. I. Lavrentyeva, A. I. Khokhlov, I. N. Kagramanyan, T. A. Gorokhova | ||
| "... necessary medical products is very significant. In the conditions of refusal of the most part ..." | ||
| Vol 10, No 1 (2017) | THE USE OF QALY AS AN INTEGRAL MEASURE OF EFFECTIVENESS IN THE EVALUATION OF MEDICAL TECHNOLOGIES | Abstract similar documents |
| N. Z. Musina, V. K. Fedyaeva | ||
| "... better decision-making on financing the medical treatment within a limited budget. With this algorithm ..." | ||
| Vol 14, No 4 (2021) | Application of medical products: mandatory requirements, supervision of their compliance | Abstract similar documents |
| O. A. Makhova | ||
| "... Background. Specific features of medical products (MPs), their active development ..." | ||
| Vol 9, No 2 (2016) | PHARMACO-ECONOMIC ANALYSIS OF COST IN TERMS OF MAINTENANCE OF PREFERENTIAL MEDICINES PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE ON THE TERRITORY OF KRASNOYARSK REGION | Abstract similar documents |
| T. V. Gaygolnik, I. V. Demko, E. N. Bochanova, A. Yu. Kraposhina, N. V. Gordeeva, I. A. Soloveva | ||
| "... and Territorial fund of obligatory medical insurance of Krasnoyarsk region on the released preferential ..." | ||
| Vol 8, No 4 (2015) | CLINICAL AND ECONOMIC EVALUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN THE TREATMENT OF CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN ADULTS | Abstract similar documents |
| E. A. Pyadushkina, M. Yu. Frolov, M. V. Avksentyeva | ||
| "... of application filing for Eltrombopag inclusion to such list, and standards of the financial expenses per medical ..." | ||
| Vol 17, No 4 (2024) | Dynamics of anticancer drug use in Russian hospitals: a five-year retrospective analysis | Abstract similar documents |
| J. A. Agafonova, V. V. Omelyanovskiy | ||
| "... analyzed medical care provided in inpatient and day hospital settings using depersonalized hospitalization ..." | ||
| Vol 7, No 1 (2014) | PHARMACOEPIDEMIOLOGY: FROM THEORY TO PRACTICE | Abstract similar documents |
| S. A. Rachina, R. S. Kozlov, Yu. A. Belkova | ||
| "... of indications lists for well recognized drugs, as well as changes in treatment strategies and prognosis for many ..." | ||
| Vol 7, No 2 (2014) | ANALYSIS OF DRUG PRODUCTS ASSORTMENT ACQUIRABLE BY HEALTHCARE ORGANIZATIONS FOR MEDICAL TREATMENT IN HOSPITAL SETTINGS WAS CONDUCTED | Abstract similar documents |
| M. G. Malaev | ||
| "... analysis of drug products assortment acquirable by healthcare organizations for medical treatment ..." | ||
| Vol 7, No 1 (2014) | ABC END VEN ANALYSYS OF COSTS FOR MEDICINE SAND MEDICAL TREATMENT COSTS PATIENT | Abstract similar documents |
| M. A. Shapovalova, L. R. Koretskaya | ||
| "... of pharmacotherapy and medical services in the department of neurology. An assessment of the costs of hospitalization ..." | ||
| Vol 17, No 1 (2024) | STEP analysis of macro-environmental factors affecting medical and drug care for patients with chronic myeloid leukemia | Abstract similar documents |
| A. V. Zhuravlev, O. I. Knysh | ||
| "... -environmental factors influencing medical and drug care for patients with chronic myeloid leukemia (CML ..." | ||
| Vol 10, No 2 (2017) | COST-MINIMIZATION OF VILANTEROL / UMECLIDINIUM VERSUS OLODATEROL / TIOTROPIUM IN THE BASIC THERAPY OF SEVERE AND VERY SEVERE COPD | Abstract similar documents |
| E. G. Kosolapov, F. S. Kochenkov, N. L. Pogudina, D. V. Blinov, N. L. Bondarenko, A. V. Karaulov | ||
| "... the public medical care and drug supply. Objective: to identify the key differences between vilantererol ..." | ||
| Vol 17, No 1 (2024) | Assessing the awareness of doctors of various specialties in the treatment of osteoporosis | Abstract similar documents |
| V. A. Alekseeva, A. V. Krikova, Т. Yu. Filatova, E. V. Dmitrieva, A. V. Ovsyankin, E. S. Kuzminova | ||
| "... underscores the need for a more comprehensive approach to this issue within the context of continuing medical ..." | ||
| Vol 6, No 3 (2013) | THE ANALYSIS OF THE MARKET OF PHARMACEUTICALS FOR DYSMENORRHEA TREATMENT | Abstract similar documents |
| N. Yu. Cherkasova, A. V. Fomina, O. V. Filippova | ||
| "... medicines have quite extensive list of the registered therapeutic indications that complicates the analysis ..." | ||
| Vol 12, No 4 (2019) | Clinical and economic analysis of drug costs in a general hospital in 2014-2018 | Abstract similar documents |
| A. T. Burbello, A. S. Fedorenko, E. L. Latariya, M. V. Pokladova, K. A. Zagorodnikova | ||
| "... and the reevaluation of the list of prescribed medications allowed us to propose the ways to optimize the structure ..." | ||
| Vol 15, No 1 (2022) | Cost-effectiveness and budget impact analyses of using implantable cardioverter-defibrillators in the Russian Federation | Abstract similar documents |
| T. O. Bessonova, F. V. Gorkavenko, D. G. Shchurov, Yu. V. Seryapina, O. R. Chetverikova, V. V. Omelyanovskiy, S. N. Krivolapov, N. M. Neminushchiy, A. A. Kalemberg | ||
| "... in accordance with general reimbursement price asserted in the high technology medical care list part 2 (HТMC 2 ..." | ||
| Vol 13, No 3 (2020) | Evaluation of the antitumor drugs therapeutic value using the method of multicriterial analysis of decision-making | Abstract similar documents |
| V. A. Lemeshko, N. Z. Musina, V. V. Omelyanovskiy | ||
| "... . At the first stage, based on the results of the publications analysis and the EVIDEM system, a list ..." | ||
| Vol 9, No 2 (2016) | MANAGEMENT ASPECT OF THE PROBLEM OF NARCOTIC DRUGS USE | Abstract similar documents |
| S. Yu. Soboleva, A. V. Sobolev, I. A. Kaminskaya | ||
| "... prevalence over medical, bioethics, economic and social aspects. The paper highlights the management ..." | ||
| Vol 15, No 2 (2022) | Improving the efficiency of the medicine provision system for patients with malignant neoplasms | Abstract similar documents |
| Yu. A. Agafonova, D. V. Fedyaev, A. V. Snegovoy, V. V. Omelyanovskiy | ||
| "... and the availability of effective medical care. The current approach of access to cancer medicines limits ..." | ||
| 1 - 50 of 336 Items | 1 2 3 4 5 6 7 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
